Releviate Therapeutics LLC, based in San Diego, CA, is a biopharmaceutical company focused on developing disease-modifying therapies for neuropathic pain. Their innovative approach targets the underlying pathology of chronic pain, aiming to reverse pathophysiology and potentially provide a cure.
With a team of experienced leaders and scientific advisors, Releviate is dedicated to addressing the unmet needs in chronic pain management. Their therapy inactivates secreted Matrix Metalloproteases (MMPs) that contribute to chronic pain, offering a unique alternative to traditional pain masking or blocking methods. Through pre-clinical studies and upcoming clinical trials, Releviate aims to provide safe and effective treatments for patients suffering from neuropathic pain.
Generated from the website